ALNY vs WYY · P/E 76, rev $1.29B vs rev $78.6M
Alnylam Pharmaceuticals Inc (ALNY) versus Widepoint C (WYY) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Widepoint C (WYY) is a information technology services company listed on AMEX.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported WYY revenue for 2026-06-30 was $78.6M. Net income was $143.4K. Revenue was up 93.7% from 2026-03-31 to 2026-06-30. WYY currently screens at market cap $129.3M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. WYY currently screens at market cap $129.3M.
Not investment advice. Open the ALNY and WYY stock pages for the full models.
Not investment advice.